Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Rallybio Corp.

0.7778
+0.05998.34%
Post-market: 0.77990.0021+0.27%19:27 EST
Volume:291.29K
Turnover:222.85K
Market Cap:32.86M
PE:-2.46
High:0.7950
Open:0.7399
Low:0.7350
Close:0.7179
52wk High:1.08
52wk Low:0.2201
Shares:42.24M
Float Shares:20.32M
Volume Ratio:1.40
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3160
EPS(LYR):-1.3268
ROE:-21.17%
ROA:-28.35%
PB:0.52
PE(LYR):-0.59

Loading ...

OverviewCompanyNewsFilings

Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026

Reuters
·
Jul 08

ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors, Strengthening Strategic Leadership

Reuters
·
Jul 07

Rallybio Corporation Announces New Employment Agreement with Chief Medical Officer, Steven Ryder, Including Enhanced Compensation and Benefits Package

Reuters
·
Jun 28

BRIEF-Rallybio Initiates Dosing In RLYB116 Phase 1 Confirmatory Study

Reuters
·
Jun 12

Rallybio Corporation Announces Initiation of Phase 1 Study for RLYB116, Targeting Immune PTR and Refractory APS

Reuters
·
Jun 12

Rallybio Corporation Conducted Annual Shareholders Meeting

Reuters
·
May 16

Analyst Rate

Hold
Buy
25.00%
Hold
75.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Sep 09, 2021

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.46
Current
-3.52
Sector Average
49.82%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.46
Maximum
-0.18
+1 STD
0.12
Minimum
-16.84
-1 STD
-7.17
Average
-3.52

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.